Stefano Piccolo - Curriculum Vitae#


EDUCATION
  • 1995 - 1998 HHMI post-doctoral fellow with Prof. Eddy De Robertis, Howard Hughes Medical Institute, University of California, Dept. of Biological Chemistry
  • 1995 PhD in Biology and Pathology of the Connective Tissue; Supervisor: Giorgio Bressan, Institute of Histology and Embryology, University of Padua, School of Medicine, Padua, Italy
  • 1991 Master in Biological Sciences, University of Padua, Italy (score: magna cum laude)

POSITIONS
  • 1998 - 2006: Assistant and then (from 2004) Associate Professor in Histology and Embryology, University of Padua, School of Medicine, Padua, Italy.
  • 2006 - present: Full Professor of Molecular Biology, University of Padua School of Medicine
  • 2017 - present: Principal Investigator at IFOM, The FIRC Institute for Molecular Oncology

AWARDS
  • 1999 International BIOTECH Award
  • 2003 A. Minich award from Istituto Veneto Scienze, Lettere ed Arti
  • 2005 International Swissbridge Award
  • 2007 Chiara D’Onofrio Award
  • 2011 International Debiopharm Award
  • 2012 International Tartufari award from Accademia Nazionale Lincei
  • 2012 Presidential Venosta award (main cancer Award in Italy) from Fondazione Italiana Ricerca sul Cancro
  • 2015 ERC Advanced Grant
  • 2017 Choh Hao Li Memorial Lectures award

INSTITUTIONAL RESPONSIBILITIES
  • 2018 - present: Member of Goverment Board of The Human Technopole Milan
  • 2015 - present: Member of AIRC Scientific Advisory Board
  • 2012 - present: Director PhD program in Molecular Medicine, University of Padua
  • 2004 - 2008: AIRC Grant review panellist

COMMISSIONS OF TRUST
  • 2013 - present EMBL Scientific Advisory board (SAC, member)
  • 2012 - 2014 ERC starting and consolidator award (member)
  • 2010 - present Pezcoller Foundation Symposia Scientific Board
  • 2012 and 2017 Pezcoller-AACR Award Committee

MEMBERSHIPS OF SCIENTIFIC SOCIETIES

  • 2007 - EMBO member
  • 2014 - Accademia dei Lincei, Rome (Member)
  • Member of AACR, SIBBM

PATENTS

  • 2017: "Compounds for somatic stem cell fate control U.S. No. 62,484,566
  • 2015: “Methods for generating somatic stem cells” PCT/EP2015/070305
  • 2011: "Composition for use in treating or preventing cancer”, PCT/EP2010/058495
  • 2010: "Prognosis of Breast Cancer Patients by monitoring two genes” PCT/EP2009/050643
  • 2007: "TGF-beta modulators and use thereof" PCT/IB2007/000233

Imprint Privacy policy « This page (revision-3) was last changed on Friday, 12. July 2019, 15:58 by System
  • operated by